4 Result(s)
within
Donald W. Northfelt
Cell Biology
-
Article
Open AccessA phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN)
Patients with ER+/HER2+ breast cancer (BC) are less likely to achieve pathological complete response (pCR) after chemotherapy with dual HER2 blockade than ER−/HER2+ BC. Endocrine therapy plus trastuzumab is ef...
-
Article
Open AccessA randomized phase 2 study of neoadjuvant carboplatin and paclitaxel with or without atezolizumab in triple negative breast cancer (TNBC) - NCI 10013
Atezolizumab with chemotherapy has shown improved progression-free and overall survival in patients with metastatic PD-L1 positive triple negative breast cancer (TNBC). Atezolizumab with anthracycline- and tax...
-
Article
Open AccessInflammatory cytokines and distant recurrence in HER2-negative early breast cancer
Systemic inflammation is believed to contribute to the distant recurrence of breast cancer. We evaluated serum samples obtained at diagnosis from 249 case:control pairs with stage II-III Her2-negative breast c...
-
Chapter
Pegylated-Liposomal Doxorubicin (Doxil®) in the Treatment of AIDS-Related Kaposi’s Sarcoma
In 1981 reports of the development of Kaposi’s sarcoma in previously healthy young homosexual men heralded the onset of the epidemic of acquired immunodeficiency syndrome (AIDS). 1–3 Kaposi’s sarcoma is the most ...
